|
Market Closed -
NYSE
21:00:02 30/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 142.57 USD | -2.15% |
|
-0.10% | +3.41% |
| 09-30 | Merck's experimental skin disease drug succeeds in mid-stage study | RE |
| 09-30 | Major drugmakers turn to China for licensing deals | RE |
Chart: Technical Analysis
NYSEUSD
| Markets | Quality | ||
|---|---|---|---|
NYSE
| NVS | Delayed | |
CBOE
| NVS | Real-time | |
London S.E.
| 0K9E | Delayed | |
Mexican S.E.
| NVS N | End-of-day quote | |
Tradegate
| NOTA | Real-time | |
Deutsche Boerse AG
| NOTA | Delayed | |
Börse Stuttgart
| NOTA | Delayed | |
Boerse Muenchen
| NOTA | Real-time | |
Swiss Exchange
| NOVN | Delayed | |
OTC Markets
| NVSEF | Delayed | |
CBOE
| 0QLR | Real-time | |
Borsa Italiana
| 1NOVN | End-of-day quote | |
Xetra
| NOT | Delayed | |
London S.E.
| 0QLR | Delayed | |
Xetra
| NOT | End-of-day quote | |
Tradegate
| NOT | Real-time | |
Boerse Muenchen
| NOT | Real-time | |
Deutsche Boerse AG
| NOT | End-of-day quote | |
Deutsche Boerse AG
| NOT | Delayed | |
Mexican S.E.
| NOVN N | End-of-day quote | |
CBOE
| Real-time | ||
CBOE
| 0QLR | Real-time | |
Börse Stuttgart
| NOT | Delayed | |
Wiener Boerse
| NOVN | End-of-day quote | |
Swiss Exchange
| NOVNEE | Delayed | |
Buenos Aires S.E.
| NVS | End-of-day quote | |
Buenos Aires S.E.
| NVSD | End-of-day quote | |
Sao Paulo
| N1VS34 | Delayed | |
Toronto S.E.
| NVS | Delayed | |
Deutsche Boerse AG
| NOT0 | Delayed | |
Deutsche Boerse AG
| NOT1 | Delayed |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Neutral |
| Resistance | 150.88 | 150.88 | 168.62 |
| Spread/Res. | -5.51% | -5.51% | -15.45% |
| Spread/Supp. | +3.94% | +3.94% | +15.17% |
| Support | 137.16 | 137.16 | 123.79 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- NOVN Stock
- NVS Stock
- Charts Novartis AG
Select your edition
All financial news and data tailored to specific country editions

















